These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27341023)

  • 21. Immunohistochemistry for the differential diagnosis of renal tumors with oncocytic features.
    Fernández-Aceñero MJ; Cazorla A; Manzarbeitia F
    Urol Oncol; 2011; 29(5):545-9. PubMed ID: 19926310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical stain for cytokeratin 7, S100A1 and claudin 8 is valuable in differential diagnosis of chromophobe renal cell carcinoma from renal oncocytoma.
    Kim SS; Choi YD; Jin XM; Cho YM; Jang JJ; Juhng SW; Choi C
    Histopathology; 2009 Apr; 54(5):633-5. PubMed ID: 19302533
    [No Abstract]   [Full Text] [Related]  

  • 23. Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics.
    Carvalho JC; Wasco MJ; Kunju LP; Thomas DG; Shah RB
    Histopathology; 2011 Jan; 58(2):169-79. PubMed ID: 21323945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
    Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
    AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma.
    Choi YD; Kim KS; Ryu S; Park Y; Cho NH; Rha SH; Jang JJ; Ro JY; Juhng SW; Choi C
    J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas.
    Herbers J; Schullerus D; Chudek J; Bugert P; Kanamaru H; Zeisler J; Ljungberg B; Akhtar M; Kovacs G
    J Pathol; 1998 Jan; 184(1):58-62. PubMed ID: 9582528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.
    Mazal PR; Exner M; Haitel A; Krieger S; Thomson RB; Aronson PS; Susani M
    Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
    Pan CC; Chen PC; Ho DM
    Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics.
    Mantilla JG; Antic T; Tretiakova M
    Hum Pathol; 2017 Aug; 66():152-158. PubMed ID: 28705707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Multiparametric MRI Useful for Differentiating Oncocytomas From Chromophobe Renal Cell Carcinomas?
    Galmiche C; Bernhard JC; Yacoub M; Ravaud A; Grenier N; Cornelis F
    AJR Am J Roentgenol; 2017 Feb; 208(2):343-350. PubMed ID: 27959744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Low-grade eosinophilic unclassified renal cell carcinoma, a recently proposed entity in the spectrum of eosinophilic renal cells tumors: Report of one case and discussion].
    Thierry S; El Alami-Thomas W; Cazin S; Chiforeanu DC; Medane S; Dugay F; Kammerer-Jacquet SF; Argani P; Laguerre B; Rioux-Leclercq N
    Ann Pathol; 2018 Dec; 38(6):395-400. PubMed ID: 30077423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
    Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
    Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caveolin-1 immunohistochemical analysis in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
    Garcia E; Li M
    Am J Clin Pathol; 2006 Mar; 125(3):392-8. PubMed ID: 16613342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
    Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
    Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of oncocytoma from chromophobe renal cell carcinoma (RCC): can novel molecular biomarkers help solve an old problem?
    Ng KL; Rajandram R; Morais C; Yap NY; Samaratunga H; Gobe GC; Wood ST
    J Clin Pathol; 2014 Feb; 67(2):97-104. PubMed ID: 24170213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactivity of CK7 across the spectrum of renal cell carcinomas with clear cells.
    Gonzalez ML; Alaghehbandan R; Pivovarcikova K; Michalova K; Rogala J; Martinek P; Foix MP; Mundo EC; Comperat E; Ulamec M; Hora M; Michal M; Hes O
    Histopathology; 2019 Mar; 74(4):608-617. PubMed ID: 30444288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence in situ hybridization as an adjunct tool in the diagnosis of primary and metastatic renal cell carcinoma in fine needle aspiration specimens.
    Kos Z; Williams PA; Belanger EC; Mai KT
    Diagn Cytopathol; 2014 Dec; 42(12):1013-23. PubMed ID: 24692327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of renal oncocytoma with focus on clinical and pathobiological aspects.
    Kuroda N; Toi M; Hiroi M; Shuin T; Enzan H
    Histol Histopathol; 2003 Jul; 18(3):935-42. PubMed ID: 12792905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncocytoma can be differentiated from its renal cell carcinoma mimics by a panel of markers: an automated tissue microarray study.
    Huang W; Kanehira K; Drew S; Pier T
    Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):12-7. PubMed ID: 18769342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of oncocytic papillary renal cell carcinoma.
    Okada A; Sasaki S; Fujiyoshi Y; Niimi K; Kurokawa S; Umemoto Y; Kohri K
    Int J Urol; 2009 Sep; 16(9):765-7. PubMed ID: 19769658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.